After a couple of great first episodes, season 18 of RuPaul’s Drag Race seemed to fall off a cliff with the advent of its ...

Wegovy launch impressive versus previous GLP-1 launches, analysts say Pill prescribed 18,410 times in the week ended January 16 FDA decision on Lilly's pill expected by April Jan 23 (Reuters) - Novo ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

French miner Eramet said on Monday it had put in place a temporary management structure to oversee its finance department, after temporary suspension its finance chief, which was not related to the ...

Shares of Novo Nordisk rose more than 8% on Friday after early prescription data showed an encouraging start to the launch of the company's new GLP-1 pill for obesity in the U.S. In a Friday note, TD ...

After launching its Wegovy pill early this month, Novo Nordisk (NVO) has garnered 3,071 U.S. prescriptions for the oral GLP-1 agonist in the first four days of its commercial rollout, Reuters reported ...

As thousands of protestors demonstrate in Washington, DC, at Friday’s annual March for Life, the Trump administration faces a deadline to explain why it opposes a lawsuit that would achieve a key goal ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug. Eli Lilly's ...

LONDON, Jan ‌16 (Reuters) - Novo Nordisk's ‌Wegovy pill hit 3,071 U.S. prescriptions ‍in the first four days ⁠after its launch, IQVIA data shared by analysts on Friday showed, as ‌investors closely ...

Monday - Friday, 6:00 - 7:00 PM ET In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the pharmaceutical giant's new pill format of its weight loss drug will allow ...

Glucagon-like peptide-1 (GLP-1) medications, such as Wegovy (semaglutide), have helped many people lose weight. Until recently, these options required regular injections — a potential dealbreaker for ...